Clinical TrialID 6133

Efficacy of ArTiMist™ in Children

NCT01047436

Falciparum Malaria

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6133
Evidence Id
6133
Core Evidence Id
6133
Source Clinical Trial Id
6119
Herb2 Clinical Trial Id
HBCT006119
Nct Id
NCT01047436
Title
Efficacy of ArTiMist™ in Children
Status
Completed
Phase
Phase 2
Study Result
Yes
Study Condition
Falciparum Malaria
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: Quinine|DRUG: Artemether
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Child, Adult, Older_Adult
Enrollment
31
Outcome Measure
Parasitological Success Defined as a Reduction in Parasite Count of ≥ 90% of Baseline at 24 Hours After the First Dose, 24 hours after first dose|Time for Parasite Count to Fall by 90% PCT(90), The time taken for the parasite count to fall 90% from baseline, 3h (hours), 6h, 12h, 18h, 24h, 30h, 36h, 48h, 54h, 60h|Time for Parasite Count to Fall by 50% PCT(50), The time taken for the parasite count to fall 50% from baseline, 3 h (hours) , 6h, 12h, 18h, 24h, 30h, 36h, 48h, 54h, 60h
Sponsor Collaborator
Proto Pharma Ltd|Xidea Solutions Limited
Funded By
INDUSTRY
Location
Other Id
ART003
Start Date
2009-12
Primary Completion Date
2010-01
Completion Date
2010-01
First Posted
2010-01-12
Results First Posted
2011-01-14
Last Update Posted
2011-01-27
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01047436
Title Cn
Title En
Efficacy of ArTiMist™ in Children
Bilingual Status
semi_complete